Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Amortizatization of Intangibles for 12 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 1.1% year-over-year to $1.7 million, compared with a TTM value of $3.8 million through Dec 2025, up 64.93%, and an annual FY2025 reading of $3.8 million, up 64.93% over the prior year.
  • Amortizatization of Intangibles was $1.7 million for Q4 2025 at Tandem Diabetes Care, up from $303000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q4 2025 and bottomed at -$1.6 million in Q3 2022.
  • Average Amortizatization of Intangibles over 5 years is -$99500.0, with a median of -$267500.0 recorded in 2021.
  • The sharpest move saw Amortizatization of Intangibles tumbled 609.42% in 2022, then surged 520.98% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$448000.0 in 2021, then crashed by 79.91% to -$806000.0 in 2022, then skyrocketed by 49.13% to -$410000.0 in 2023, then soared by 520.98% to $1.7 million in 2024, then increased by 1.1% to $1.7 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for TNDM at $1.7 million in Q4 2025, $303000.0 in Q3 2025, and $632000.0 in Q2 2025.